TSW
Thompson Siegel & Walmsley’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
266,387
+93,603
| +54% | +$437K | 0.02% | 285 |
|
|
2025
Q1 | $949K | Buy |
172,784
+20,000
| +13% | +$110K | 0.02% | 282 |
|
|
2024
Q4 | $518K | Sell |
152,784
-20,000
| -12% | -$67.8K | 0.01% | 312 |
|
|
2024
Q3 | $492K | Hold |
172,784
| – | – | 0.01% | 321 |
|
|
2024
Q2 | $389K | Sell |
172,784
-17,216
| -9% | -$38.8K | 0.01% | 311 |
|
|
2024
Q1 | $420K | Buy |
+190,000
| New | +$420K | 0.01% | 307 |
|
|
2021
Q3 | – | Sell |
-62,000
| Closed | -$252K | – | 749 |
|
|
2021
Q2 | $252K | Buy |
62,000
+17,000
| +38% | +$69.1K | ﹤0.01% | 354 |
|
|
2021
Q1 | $203K | Buy |
45,000
+43,750
| +3,500% | +$197K | ﹤0.01% | 353 |
|
|
2020
Q4 | $6K | Buy |
+1,250
| New | +$6K | ﹤0.01% | 631 |
|